UPDATE: Jefferies Cuts PT to $19 on LHC Group; Cost Management Continuity Concerns

Loading...
Loading...
Jefferies lowers its price target from $20 to $19 on Hold-rated LHC Group
LHCG
reflecting concerns that the company's expense management, currently strong, may not be sustainable. Jefferies notes, "LHCG's terrific job of tightening costs during Q1 yielded a robust beat vs. consensus. However, based on management's reaffirmed guidance, we are concerned that this tightening may only be "window dressing" as part of the company's review of its strategic alternatives. Reiterate Hold/$19PT (from $20)." LHCG closed at $17.13 on Wednesday.
Market News and Data brought to you by Benzinga APIs
Posted In: Analyst ColorPrice TargetReiterationPre-Market OutlookAnalyst RatingsHealth CareHealth Care ServicesJefferies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...